References
- Eriksson E, Replogle RL, Glagov S. Reperfusion of skeletal muscle after warm ischemia. Ann Plast Surg. 1987; 18: 224–229
- Strock PE, Majno G. Vascular responses to experimental tourniquet ischemia. Surg Gynecol Obstet. 1969; 129: 309–318
- Manson PN, Anthenelli RM, Bulkley GB, Hoopes JE. The role of oxygen free radicals in ischemic tissue injury in skin flaps. Ann Surg. 1985; 198: 87–90
- Del Maestro RF, Thaw HT, Bjor J, Planker MA, Arros K. Free radicals as mediators of tissue injury. Acta Physiol Scand. 1980; 492: 43
- McCord JE. Oxygen derived free radicals in post ischemic tissue injury. N Engl J Med. 1985; 312(3)159–163
- Walker PM, Lindsay TF, Labbe R, Mickle DA, Romaschin AD. Salvage of skeletal muscle with free radical scavengers. J Vase Surg. 1987; 5: 68–75
- Haber F, Weiss J. The catalytic decomposition of hydrogen peroxide in iron salts. J Proc R Soc A. 1934; 147: 332–351
- Halliwell B. Superoxide-dependent formation of hydroxyl radicals in the presence of iron salts. FEBS Lett. 1978; 96: 238–242
- Halliwell B, Guttenridge JM. Iron and free radical reactions: two aspects of antioxidant protection. Trends Biochem Sci. 1986; 11: 372–375
- Halliwell B, Guttenridge JM. Oxygen toxicity, oxygen radicals, transition metals and disease. Biochem J. 1984; 219: 1–14
- Menasche P, Pasqvier C, Bellucci S, Lorente P, Jaillon P, Armand P. Deferoxamine reduces neutrophil-mediated free radical production during cardiopulmonary bypass in man. J Thorac Cardiovasc Surg. 1988; 96: 582–589
- Thomas CE, Morehouse LA, Aust SD. Ferritin and superoxide dependent lipid peroxidation. J Biol Chem. 1985; 260: 3275
- Gutteridge JMC, Richmond R, Halliwell B. Inhibition of the iron catalyzed formation of hydroxyl radicals from superoxide and of lipid peroxidation by deferoxamine. Biochem J. 1979; 184: 469
- Aust SD, White BD. Iron chelation prevents tissue injury following ischemia. Adv Free Radic Biol Med. 1985; 1: 1–17
- Finklenstein I, Toledo-Pereyra LH, Castrillo M, Castellanos J. Comparative analysis of pharmacological agents following small bowel ischemia. Transplant Proc. 1988; 5: 1034–1044
- Paller MS, Hedlind BE. Role of iron in postischemic renal injury in the rat. Kidney Int. 1988; 34: 474–480
- Haung L, Privalle CT, Serafin D, Klitzman B. Increased survival of skin flaps by scavengers of superoxide radicals. FASEB J. 1987; 1(2)129–132
- Angel MF, Narayanan K, Swartz WM. Deferoxamine increases skin flap survival: additional evidence of free radicals involvement in ischemic flap surgery. Br J Plast Surg. 1986; 3A: 469–472
- Ambrosio MD, Zweier JL, Jacobos WE, Weisfeldt ML, Flaberty JT. Improvement of postishemic myocardiac function and metabolism induced by administration of desferol at the time of reflow: the role of iron in the pathogenesis of reperfusion injury. Circulation. 1987; 76(4)906–915
- Wickens DG, Atkin G, Fuller BJ, Hobbs HF, Dormardy TL. Free radicals in hypothermic rat heart preservation-prevention of damage by mannitol and deferoxamine. Free Radic Res Commun. 1987; 4(3)189–95
- Wood MA, Hess ML. The effects of dihydroxyfumarate on isolated rabbit papillary muscle function: evidence for an iron dependent non-hydroxyl radical mechanism. Mol Cell Biochem. 1987; 78: 161–167
- Cooper BA, Bunn RD, Propper DG, Nathan DS, Rosenthal PF, Moleney WC. Treatment of iron overload in adults with continuous deferoxamine. Am J Med. 1977; 63: 959
- Mitsos S, Locches B, Fantone J. Modulation of hemoprotein H2O2 mediated peroxidation reactions by sulfhydryl compounds: relations to myocardial infarction. Fed Proc. 1985; 44: 1839
- Sadrzadeh SMH, Graf E, Panter SS, Halloway PE, Eaton JW. Hemoglobin a biologic ferri-tein reagent. J Biol Chem. 1984; 259: 14344–14356
- Rubin M, Faber E. Inflammation: Pathology. Lippincott, New York 1988; 37–62